➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Express Scripts
AstraZeneca
Baxter
McKinsey

Last Updated: June 20, 2021

DrugPatentWatch Database Preview

VANOS Drug Profile


Email this page to a colleague

« Back to Dashboard

When do Vanos patents expire, and what generic alternatives are available?

Vanos is a drug marketed by Medicis and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has eleven patent family members in nine countries.

The generic ingredient in VANOS is fluocinonide. There are nine drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vanos

A generic version of VANOS was approved as fluocinonide by COSETTE on December 2nd, 1988.

  Try Before You Buy

Paragraph IV (Patent) Challenges for VANOS
Tradename Dosage Ingredient NDA Submissiondate
VANOS CREAM;TOPICAL fluocinonide 021758 2008-01-31

US Patents and Regulatory Information for VANOS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes   Try Before You Buy   Try Before You Buy   Try Before You Buy
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes   Try Before You Buy   Try Before You Buy Y   Try Before You Buy
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes   Try Before You Buy   Try Before You Buy   Try Before You Buy
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes   Try Before You Buy   Try Before You Buy Y   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
Harvard Business School
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.